Phosphodiesterase type 5 inhibitors improve microvascular dysfunction markers in pulmonary arterial hypertension associated with congenital heart disease

Congenital Heart Disease, EarlyView.

Source: Congenital Heart Disease - October 21, 2018 Category: Cardiology Authors: Mariana M. Clav é, Nair Y. Maeda, Ana M. Thomaz, Sergio P. Bydlowski, Antonio A. Lopes Source Type: research